Module

Emerging Biology of Breast Cancer: Circulating Tumor Cells

Source: Breast Cancer Annual Update 2005

Emerging Biology of Breast Cancer: Circulating Tumor Cells


Program Director: Clifford A. Hudis, MD

Faculty:

  • Daniel F. Hayes, MD
  • Jeffrey B. Smerage, MD, PhD

CME CREDIT INFORMATION

Release Date: 10/11/05

Expiration Date: 10/10/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate circulating tumor cells as prognostic factors in metastatic breast cancer.

  • Describe methods used to detect circulating tumor cells in peripheral blood.

  • Identify obstacles in collecting, analyzing, and interpreting data from circulating tumor cell assays.


Content includes:

  • Technologies for CTC Detection
  • CTC Counts as Prognostic Factors in Breast Cancer
  • Role of CTC Counts in Monitoring Therapy
  • CTC Biology
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.